By Professor Andrew Lloyd

Journal articles

Vollmer-Conna U ; Cameron B ; Hadzi-Pavlovic D ; Singletary K ; Davenport T ; Vernon S ; Reeves WC ; Hickie I ; Wakefield D ; Lloyd AR ; Dubbo Infection Outcomes Study Group , 2007, 'Post-infective fatigue syndrome is not associated with altered cytokine production', Clin Infect Dis., 45, pp. 732 - 735

Dyer W; Pett SL; Sullivan JS; Emery S; Cooper DA; Kelleher AD; Lloyd AR; Lewin S, 2007, 'Substantial improvements in performance indicators achieved in a peripheral blood mononuclear cell cryopreservation quality assurance program using single donor samples', Clinical and Vaccine Immunology, 14, pp. 52 - 59

Bennett BK; Goldstein D; Lloyd AROLA; Friedlander ML; Hickie IB, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: a qualitative and comparative study', Journal of Pain and Symptom Management, 34, pp. 126 - 135

Bennett BK; Goldstein D; Friedlander ML; Hickie IB; Lloyd AR, 2007, 'The experience of cancer-related fatigue and chronic fatigue syndrome: A qualitative and comparative study', Journal of Pain and Symptom Management, 34, pp. 126 - 135

Dore GJ; Hellard M; Matthews G; Haber PS; Shaw D; Yeung B; Petoumenos K; Van Beek IA; Mccaughan GW; Pan Y; Ffrench R; Rowlinson W; Lloyd AR; Kaldor JM, 2007, 'Treatment of recently acquired hepatitis C infection in injecting drug users: Preliminary results from the Australian trial in acute hepatitis C (ATAHC)', Hepatology, 46, pp. 358A - 358A

Vernon SD; Whistler T; Cameron B; Hickie IB; Reeves WC; Lloyd A, 2006, 'Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr virus.', BMC infectious diseases, 6

Palmer C; Lloyd AR; Yan KK; Hampartzoumian T; Zekry A, 2006, 'Effect of adipokines on T-CELL mediated anti-HCV immune responses', Hepatology, 44, pp. 297A - 298A, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000241362300290&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Ng WW; Lloyd AR; Grimm M, 2006, 'Appendicitis protects against colitis: an exploration of immune mechanisms', Journal of Gastroenterology and Hepatology, 21, pp. A263 - A263

Vernon SD; Nicholson A; Rajeevan M; Dimulescu I; Cameron B; Whistler T; Lloyd A, 2006, 'Correlation of psycho-neuroendocrine-immune (PNI) gene expression with symptoms of acute infectious mononucleosis', Brain Res, 1068, pp. 1 - 6, http://dx.doi.org/10.1016/j.brainres.2005.11.013

Fostel J; Boneva R; Lloyd AR, 2006, 'Exploration of the gene expression correlates of chronic unexplained fatigue using factor analysis', Pharmacogenomics, 7, pp. 441 - 454

Goldstein D; Bennett BK; Friedlander ML; Davenport TA; Hickie IB; Lloyd AR, 2006, 'Fatigue states after cancer treatment occur both in association with, and independent of, mood disorder: a longitudinal study', BMC Cancer, 6, pp. 240 - 240, http://dx.doi.org/10.1186/1471-2407-6-240

Elliott LN; Hossieny P; Lloyd AR; Ffrench RA, 2006, 'High prevalence of broadly reactive HCV-specific cellular immune responses in antibody and PCR negative prisoners reporting injecting drug use', Journal of Clinical Virology, 36, pp. S122 - S122

Hickie I; Davenport TA; Wakefield D; Vollmer-Conna US; Cameron BA; Vernon S; Reeves W; Lloyd AR, 2006, 'Postinfective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: porspective cohort study', British Medical Journal: International, Sep, pp. 1 - 6

Vernon S ; Whistler T ; Cameron B ; Hickie I ; Reeves W ; Lloyd A ; Cameron B; Lloyd A; Hickie I, 2006, 'Preliminary evidence of mitochondrial dysfunction associated with post-infective fatigue after acute infection with Epstein Barr Virus', BMC Infect Dis, 6, pp. 15, http://dx.doi.org/10.1186/1471-2334-6-15

Cameron B; Bharadwaj M; Burrows J; Fazou C; Wakefield D; Hickie I; Ffrench R; Khanna R; Lloyd A, 2006, 'Prolonged illness after infectious mononucleosis is associated with altered immunity but not with increased viral load', J Infect Dis, 193, pp. 664 - 671, http://dx.doi.org/10.1086/500248

Elliott LN; Lloyd AR; Ziegler JB; Ffrench RA, 2006, 'Protective immunity against hepatitis C virus infection', Immunology and Cell Biology, 84, pp. 239 - 249

Wallace C; Hailstone S; Lloyd A, 2005, 'Bug Breakfast in the Bulletin: Blood-borne viruses in correctional facilities.', New South Wales public health bulletin, 16, pp. 166 - 167

Elliott LN; Ziegler JB; Palasanthiran P; Giles ME; Lloyd AR; Ffrench R, 2005, 'Infrequent detection of HCV-specific cellular immune responses in infants born to HCV-positive mothers', Tissue Antigens, 66, pp. 405 - 406, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700176&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Harvey CE; Lloyd AR; Post JJ, 2005, 'Loss of CCR5+ T cells in the liver of HCV infected individuals co-infected with HIV', Tissue Antigens, 66, pp. 437 - 438, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700261&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Flynn J; Goy K; Woollard D; Lloyd AR; Ffrench R, 2005, 'Multi-specific IFN-gamma and IL-2 T cell responses in chronic HCV infection', Tissue Antigens, 66, pp. 419 - 419, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700212&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Jagger E; Hettiaratchi A; Carol H; Cameron BA; Vollmer-Conna US; Davenport T; Hickie IB; Wakefield D; Lloyd AR, 2005, 'Polymorphisms in the interleukin-10 gene are associated with duration of illness following primary Epstein-Barr virus infection', Tissue Antigens, 66, pp. 452 - 453, http://gateway.webofknowledge.com/gateway/Gateway.cgi?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000233542700302&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a

Smith A; Vollmer-Conna US; Geczy A; Dunckley H; Bennett BK; Hickie IB; Lloyd AR, 2005, 'Does genotype mask the relationship between psychological factors and immune function?', Brain Behavior and Immunity, 19, pp. 147 - 152

Helbig K; Ayres J; Dunckley H; Lloyd AR; Robson J; Marmion BP; Harris R, 2005, 'Immune response genes in the post-Q-fever fatigue syndrome, Q fever endocarditis and uncomplicated acute primary Q fever', QJM - an International Journal of Medicine, 98, pp. 565 - 574

Freeman AJ; Marinos G; Ffrench R; Lloyd AR, 2005, 'Intrahepatic and peripheral blood virus-specific cytotoxic T lymphocyteactivity is associated with a response to combination IFN-alpha andribavirin treatment among patients with chronic hepatitis C virusinfection', Journal of Viral Hepatitis, 12, pp. 125 - 129

Newman R; Cuan N; Hampartzoumian T; Connor SJ; Lloyd AR; Grimm M, 2005, 'Vasoactive intestinal peptide impairs leucocyte migration but fails to modify experimental murine colitis', Clinical and Experimental Immunology, 139, pp. 411 - 420

Scroop GC; Burnet RB, 2004, 'To exercise or not to exercise in chronic fatigue syndrome?', MEDICAL JOURNAL OF AUSTRALIA, 181, pp. 578 - 579, http://dx.doi.org/10.5694/j.1326-5377.2004.tb06457.x

Pett SL; Williams LA; Day RO; Lloyd AR; Carr AD; Clezy KR; Emery S; Kaplan E; Mcphee D; Mclachlan AJ; Gelder F; Lewin S; Liauw WS; Williams KM, 2004, 'A phase I study of the pharmacokinetics and safety of passive immunotherapy with caprine anti-HIV antibodies, (PE)HRG214, in HIV-1-infected individuals', HIV Clinical Trials, 5, pp. 91 - 98

Connor SJ; Paraskevopoulos N; Newman R; Cuan N; Hampartzoumian T; Lloyd AR; Grimm M, 2004, 'CCR2 expressing CD4+T lymphocytes are preferentially recruited to the ileum in Crohn's disease', Gut, 53, pp. 1287 - 1294

Post JJ; Pan Y; Freeman AJ; Harvey CE; White PA; Palladinetti P; Haber P; Marinos G; Levy MH; Kaldor JM; Dolan K; Ffrench R; Lloyd AR; Rawlinson WD, 2004, 'Clearance of Hepatitis C Viremia Associated with Cellular Immunity in the Absence of Seroconversion in the Hepatitis C Incidence and Transmission in Prisons Study Cohort', Journal of Infectious Diseases, 189, pp. 1846 - 1855

Bennett BK; Goldstein D; Lloyd AR; Davenport T; Hickie IB, 2004, 'Fatigue and psychological distress - exploring the relationship in women treated for breast cancer', European Journal of Cancer, 40, pp. 1689 - 1695

Freeman A; Ffrench R; Post JJ; Harvey CE; Gilmour S; White PA; Marinos G; Van Beek IA; Rawlinson WD; Lloyd AR, 2004, 'Prevalence of Production of Virus-Specific Interferon- among Seronegative Hepatitis C-Resistant Subjects Reporting Injection Drug Use', Journal of Infectious Diseases, 190, pp. 1093 - 1097

Vollmer-Conna U; Fazou C; Cameron B; Li H; Brennan C; Luck L; Davenport T; Wakefield D; Hickie I; Lloyd A, 2004, 'Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans', Psychol Med, 34, pp. 1289 - 1297

Stafford JA; Post JJ; Kaldor JM; Pan Y; Haber P; Lloyd AR; Dolan K, 2004, 'Risk factors for hepatitis C infection and perception of antibody status among male prison inmates in the Hepatitis C Incidence and Transmission in Prisons Study Cohort, Australia', Journal of Urban Health - Bulletin of the New York Academy of Medicine, 81, pp. 448 - 452, http://dx.doi.org/10.1093/jurban/jth129

Smith A; Vollmer-Conna US; Bennett BK; Wakefield D; Hickie IB; Lloyd AR, 2004, 'The relationship between distress and the development of a primary immune response to a novel antigen', Brain Behavior and Immunity, 18, pp. 65 - 75

Lloyd AR, 2004, 'To exercise or not to exercise in chronic fatigue syndrome?', Medical Journal of Australia, 181, pp. 578 - 580, http://dx.doi.org/10.5694/j.1326-5377.2004.tb06459.x

Lloyd AR, 2004, 'To exercise or not to exercise in chronic fatigue syndrome? No longer a question', Medical Journal of Australia, 180, pp. 437 - 438

Lloyd AR, 2004, 'To exercise or not to exercise in chronic fatigue syndrome? Reply', Medical Journal of Australia, 181, pp. 579 - 580

Freeman AJ; Ffrench RA; Post JJ; Harvey CE; Gilmour S; White PA; Marinos G; Rawlinson WD; Van Beek IA; Lloyd AR, 2004, 'Virus-specific cellular immunity is prevalent among hepatitis C-resistant injecting drug users', Journal of Infectious Diseases, 190, pp. 1093 - 1097

Grimm MC; Newman R; Hassim Z; Cuan N; Connor SJ; Le Y; Wang JM; Oppenheim JJ; Lloyd AR, 2003, 'Cutting Edge: Vasoactive Intestinal Peptide Acts as a Potent Suppressor of Inflammation In Vivo by Trans-Deactivating Chemokine Receptors', Journal of Immunology, 171, pp. 4990 - 4994, http://dx.doi.org/10.4049/jimmunol.171.10.4990

Vollmer-Conna U; Davenport T; Hickie I; Wakefield D; Lloyd A, 2003, 'Sick, sleepy and sad', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55, pp. 95 - 95, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186983200420&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smith AJ; Vollmer-Conna U; Bennett B; Wakefield D; Hickie IB; Lloyd AR, 2003, 'The effect of examination stress on the development of a primary immune response', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55, pp. 28 - 28, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186983200109&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Smith AJ; Bennett B; Vollmer-Conna U; Wakefield D; Hickie IB; Lloyd AR, 2003, 'The relationship between distress and the development of a primary immune response', AUSTRALIAN JOURNAL OF PSYCHOLOGY, 55, pp. 92 - 92, https://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=PARTNER_APP&SrcAuth=LinksAMR&KeyUT=WOS:000186983200402&DestLinkType=FullRecord&DestApp=ALL_WOS&UsrCustomerID=891bb5ab6ba270e68a29b250adbe88d1

Harvey CE; Post JJ; Palladinetti P; Freeman AJ; Ffrench R; Kumar RK; Marinos G; Lloyd AR, 2003, 'Expression of the chemokine IP-10 (CXCL10) by hepatocytes in chronic hepatitis C virus infection correlates with histological severity and lobular inflammation', Journal of Leukocyte Biology, 74, pp. 360 - 369

Reeves W; Lloyd AR; Vernon S; Klimas N; Jason L; Bleijenberg G; Evengard B; White P; Nisenbaum R; Unger E, 2003, 'Identification of ambiguities in the 1994 chronic fatigue syndromeresearch case definition and recommendations for resolution', BMC Health Services Research, 3, pp. 1 - 9, http://dx.doi.org/10.1186/1472-6963-3-1

Robertson PW; Beynon S; Whybin R; Brennan CM; Vollmer-Conna US; Hickie IB; Lloyd AR, 2003, 'Measurement of EBV-1gG and t-VCA avidity aids the early and reliable diagnosis of primary EBV infection', Journal of Medical Virology, 70, pp. 617 - 623

Senanayake SN; Kelly JJ; Lloyd AR; Waliuzzaman Z; Goldstein D; Rawlinson WD, 2003, 'Multicentric Castleman's Disease Treated with Antivirals and Immunosuppressants', Journal of Medical Virology, 71, pp. 399 - 403

Xue ML; Wakefield D; Willcox MD; Lloyd AR; Di Girolamo N; Cole NA; Thakur A, 2003, 'Regulation of MMPs and TIMPs by IL-1â during Corneal Ulceration and Infection', Investigative Ophthalmology and Visual Science, 44, pp. 2020 - 2025

Xue ML; Thakur A; Willcox MD; Zhu H; Lloyd AR; Wakefield D, 2003, 'Role and regulation of CXC-chemokines in acute experimental keratitis', Experimental Eye Research, 76, pp. 221 - 231

Freeman A; Pan Y; Harvey CE; Post JJ; Law MG; White PA; Rawlinson WD; Lloyd AR; Marinos G; Ffrench R, 2003, 'The presence of an intrahepatic cytotoxic T lymphocyte response is associated with low viral load in patients with chronic hepatitis C virus infection', Journal of Hepatology, 38, pp. 349 - 356

Grimm M; Newman R; Hassim Z; Cuan N; Connor SJ; Wang J; Oppenheim JJ; Lloyd AR, 2003, 'Vasoactive intestinal peptide acts as a potent suppressor of inflammation in vivo by trans-deactivating chemokine receptors', Journal of Immunology, 171, pp. 4990 - 4994

Back to profile page